An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said
Monday. Gantenerumab is part of a class of injected drugs that are designed to remove sticky protein pieces called beta amyloid from the brain. Beta amyloid buildup is a hallmark of Alzheimer’s disease. Most of these drugs have worked as intended to clear the beta amyloid, but many have still failed to demonstrate any real-life benefits to patients; their brain function and memory doesn’t improve significantly, despite treatment.
The results for gantenerumab follow positive results for a different beta amyloid reducing drug, lecanemab. The companies testing that medication, Biogen and Eisai, announced this year that lecanemab had slowed the decline of brain function in Alzheimer’s disease by about 27% compared with a placebo.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
CIA Director Bill Burns meeting with Russian counterpart Monday | CNN PoliticsCIA Director Bill Burns is meeting with his Russian intelligence counterpart, Sergey Naryshkin, in Ankara Monday as part of an ongoing effort by the US to 'communicate with Russia on managing risk' and to discuss the cases of 'unjustly detained US citizens,' a National Security Council spokesperson tells CNN.
続きを読む »
Video: Is 'quiet quitting' over on CNN Nightcap | CNN BusinessInsider's senior correspondent Aki Ito tells 'Nightcap's' Jon Sarlin why a recruiter who embraced 'quiet quitting' is now back to working 50 hours a week and why 'quiet quitters' may now be losing their bargaining power at work. For more, watch the full Nightcap episode here.
続きを読む »
USAF's experimental space plane home after record flight | Digital TrendsThe Air Force’s experimental X37B spaceplane has returned to Earth after a record mission lasting 908 days, beating its previous stay in space by 129 days.
続きを読む »
Why Doctors Are Intrigued By Experimental High Blood Pressure Medication BaxdrostatPeople on the medication saw an impressive blood pressure drop of 20 points in a clinical trial.
続きを読む »
Experimental Alzheimer's drug fails to slow cognitive decline in clinical trialsAn experimental Alzheimer's drug failed to slow cognitive decline in a long-awaited trial, marking the latest disappointment in a research field that has been wrought with setbacks.
続きを読む »
Suns update: Chris Paul (heel) questionable, Landry Shamet (concussion) out Monday at MiamiPhoenix Suns point guard Chris Paul is listed as questionable and guard Landry Shamet (concussion protocol) is ruled out Monday's game at Miami.
続きを読む »